管腔形成術の市場：手術手技別、用途別-2025年～2030年の世界予測

管腔形成術市場は、2023年に5億1,726万米ドルと評価され、2024年には5億5,404万米ドルに達すると予測され、CAGR 7.26%で成長し、2030年には8億4,515万米ドルに達すると予測されています。

管腔形成術は、主に開放隅角緑内障の治療に使用される外科的処置で、眼球の自然な体液の排出を促進し、眼圧を低下させます。管腔形成術の必要性は、緑内障の有病率の上昇、人口の高齢化、薬物療法やレーザー治療のような従来の治療法の限界から生じています。管腔形成術は、シュレム管の拡張を伴う低侵襲な手術であり、従来のトラベクレクトミーに代わる魅力的な治療法です。非侵襲的な手術に対する需要の増加に伴い、最終用途の範囲は主に眼科クリニック、外来手術センター、病院をカバーしており、そこでは患者に高度な治療オプションが提供されます。管腔形成術市場の主な成長要因としては、より安全で迅速な手術につながる技術の進歩、緑内障の早期発見に対する意識の高まり、保険適用の拡大などが挙げられます。最新の潜在機会は、ヘルスケアのインフラが進歩し続け、管腔形成術を実施するための人材育成が進んでいる新興市場に見られます。効果的な戦略には、眼科機器企業との提携が含まれ、最先端技術を統合し、個別化された治療計画のためにビッグデータを活用します。しかし、市場成長の課題として、高い治療費、熟練した専門家の不足、新製品の承認を遅らせる厳しい規制ガイドラインがあります。さらに、管腔形成術になじみがないため、患者が従来の治療を好むこともハードルとなっています。より費用対効果の高い機器やツールの開発におけるイノベーションは、これらの制限の一部を緩和することができます。調査の焦点は、治療結果の向上、コストの最小化、そして未開拓の市場に参入するためのアクセシビリティの拡大です。市場は競争的であり、現在は絶え間ない技術革新と手術手技の洗練が原動力となっているが、戦略的提携、従来の治療法に対する利点に関する重点的な教育、規制上の課題への効率的な対処によって、大きな成長の可能性があります。

市場力学：急速に進化する管腔形成術市場の主要市場インサイトを公開

管腔形成術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の緑内障有病率の上昇に伴う老人人口の増加
  • 緑内障啓発に関する政府の取り組み
  • ヘルスケアインフラの成長と低侵襲手術への嗜好性
• 市場抑制要因
  • 管腔形成術機器の高コストと保険適用のばらつき
• 市場機会
  • より高度でユーザーフレンドリーな管腔形成術機器開発のための研究開発投資
  • 医療機器メーカー、製薬会社、ヘルスケア機関とのパートナーシップの構築
• 市場の課題
  • 合併症のリスクを伴う進行緑内障に対する管腔形成術の限定的な有効性

ポーターのファイブフォース：管腔形成術市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、管腔形成術市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：管腔形成術市場における外部からの影響の把握

外部マクロ環境要因は、管腔形成術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析管腔形成術市場における競合情勢の把握

管腔形成術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス管腔形成術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、管腔形成術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨管腔形成術市場における成功への道筋を描く

管腔形成術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口の増加と世界中で緑内障の罹患率の増加
    • 緑内障啓発に関する政府の取り組み
    • ヘルスケアインフラの拡大と低侵襲手術の好感度
  • 抑制要因
    • 管腔形成術デバイスの高コストと保険適用範囲のばらつき
  • 機会
    • より先進的で使いやすい管腔形成術デバイスの開発に向けた研究開発への投資
    • 医療機器メーカー、製薬会社、ヘルスケア機関間の新たなパートナーシップ
  • 課題
    • 合併症のリスクがある進行した緑内障に対する管腔形成術の有効性は限られている
• 市場セグメンテーション分析
  • 手術技術：低侵襲性のため、腹腔内手術がますます好まれる傾向にある
  • 応用：病院や眼科クリニックにおける管腔形成術の新たな応用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 管腔形成術の市場：手術手技別

• Ab-Externo管腔形成術
• Ab-Interno管腔形成術

第7章 管腔形成術の市場：用途別

• アカデミー＆調査室
• 外来手術センター
• 病院・眼科

第8章 南北アメリカの管腔形成術の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の管腔形成術の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの管腔形成術の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • FDA、ノヴァ・アイ・メディカルの低侵襲眼科手術の進歩を承認
  • Sight Sciences、強化された管腔形成術手順を実現するErgoシリーズOmniRを発売
  • ベラナヘルスとサイトサイエンスの調査提携により緑内障治療の新たな境地を切り開く
• 戦略分析と提言

企業一覧

• Carl Zeiss Meditec AG
• Ellex Medical Pty Ltd.
• Glaukos Corporation
• iSTAR Medical
• Nova Eye Medical Limited
• Qura, Inc.
• Sight Sciences, Inc.

LIST OF FIGURES

• FIGURE 1. CANALOPLASTY MARKET RESEARCH PROCESS
• FIGURE 2. CANALOPLASTY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CANALOPLASTY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CANALOPLASTY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CANALOPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CANALOPLASTY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CANALOPLASTY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS CANALOPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS CANALOPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES CANALOPLASTY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES CANALOPLASTY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. CANALOPLASTY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. CANALOPLASTY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CANALOPLASTY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CANALOPLASTY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CANALOPLASTY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CANALOPLASTY MARKET DYNAMICS
• TABLE 7. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CANALOPLASTY MARKET SIZE, BY AB-EXTERNO CANALOPLASTY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CANALOPLASTY MARKET SIZE, BY AB-INTERNO CANALOPLASTY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CANALOPLASTY MARKET SIZE, BY ACADEMY & RESEARCH LABORATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS & OPHTHALMOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES CANALOPLASTY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM CANALOPLASTY MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM CANALOPLASTY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. CANALOPLASTY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. CANALOPLASTY MARKET, FPNV POSITIONING MATRIX, 2023

The Canaloplasty Market was valued at USD 517.26 million in 2023, expected to reach USD 554.04 million in 2024, and is projected to grow at a CAGR of 7.26%, to USD 845.15 million by 2030.

Canaloplasty is a surgical procedure primarily used to treat open-angle glaucoma by enhancing the drainage of the eye's natural fluids, thus reducing intraocular pressure. The necessity for canaloplasty arises from the rising prevalence of glaucoma, an aging population, and the limitations of conventional therapies like medication or laser treatments. Its application is performing a minimally invasive procedure that involves the dilation of Schlemm's canal, and thus it presents an appealing alternative to traditional trabeculectomy. With an increasing demand for non-invasive surgeries, the end-use scope predominantly covers ophthalmic clinics, ambulatory surgical centers, and hospitals, where patients are offered advanced treatment options. Key growth influencers of the canaloplasty market include technological advancements leading to safer, faster procedures, growing awareness of early glaucoma detection, and insurance coverage expansion. The latest potential opportunities are seen in emerging markets where healthcare infrastructure continues to advance, and there's increasing personnel training to perform canaloplasty. Effective strategies involve partnerships with ophthalmic device companies to integrate cutting-edge technology and leverage big data for personalized treatment plans. However, market growth is challenged by high procedure costs, a shortage of skilled professionals, and stringent regulatory guidelines that can delay new product approvals. Furthermore, patients' preference for traditional treatments due to unfamiliarity with canaloplasty presents another hurdle. Innovating in the development of more cost-effective devices or tools can mitigate some of these limitations. Research could focus on enhancing procedural outcomes, minimizing costs, and expanding accessibility to further penetrate untapped markets. The market is competitive, currently driven by continuous innovation and the refinement of surgical techniques, but there is significant potential for growth through strategic alliances, focused education on benefits over conventional treatments, and addressing regulatory challenges efficiently.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Canaloplasty Market

The Canaloplasty Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing geriatric population, along with the increasing prevalence of glaucoma worldwide
  • Government initiatives regarding glaucoma awareness
  • Growing healthcare infrastructure and preference for minimally invasive surgeries
• Market Restraints
  • High cost of canaloplasty devices and variability in insurance coverage
• Market Opportunities
  • Investment in R&D for developing more advanced, user-friendly canaloplasty devices
  • Emerging partnerships between medical device manufacturers, pharmaceutical companies, and healthcare institutions
• Market Challenges
  • Limited efficacy of canaloplasty for advanced glaucoma with risk of complications

Porter's Five Forces: A Strategic Tool for Navigating the Canaloplasty Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Canaloplasty Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Canaloplasty Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Canaloplasty Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Canaloplasty Market

A detailed market share analysis in the Canaloplasty Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Canaloplasty Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Canaloplasty Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Canaloplasty Market

A strategic analysis of the Canaloplasty Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Canaloplasty Market, highlighting leading vendors and their innovative profiles. These include Carl Zeiss Meditec AG, Ellex Medical Pty Ltd., Glaukos Corporation, iSTAR Medical, Nova Eye Medical Limited, Qura, Inc., and Sight Sciences, Inc..

Market Segmentation & Coverage

This research report categorizes the Canaloplasty Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Surgical Technique, market is studied across Ab-Externo Canaloplasty and Ab-Interno Canaloplasty.
• Based on Application, market is studied across Academy & Research Laboratory, Ambulatory Surgical Centers, and Hospitals & Ophthalmology Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing geriatric population, along with the increasing prevalence of glaucoma worldwide
    • 5.1.1.2. Government initiatives regarding glaucoma awareness
    • 5.1.1.3. Growing healthcare infrastructure and preference for minimally invasive surgeries
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of canaloplasty devices and variability in insurance coverage
  • 5.1.3. Opportunities
    • 5.1.3.1. Investment in R&D for developing more advanced, user-friendly canaloplasty devices
    • 5.1.3.2. Emerging partnerships between medical device manufacturers, pharmaceutical companies, and healthcare institutions
  • 5.1.4. Challenges
    • 5.1.4.1. Limited efficacy of canaloplasty for advanced glaucoma with risk of complications
• 5.2. Market Segmentation Analysis
  • 5.2.1. Surgical Technique: Growing preference for the ab-interno canaloplasty technique for its minimally invasive nature
  • 5.2.2. Application: Emerging applications of canaloplasty in hospitals and ophthalmology clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Canaloplasty Market, by Surgical Technique

• 6.1. Introduction
• 6.2. Ab-Externo Canaloplasty
• 6.3. Ab-Interno Canaloplasty

7. Canaloplasty Market, by Application

• 7.1. Introduction
• 7.2. Academy & Research Laboratory
• 7.3. Ambulatory Surgical Centers
• 7.4. Hospitals & Ophthalmology Clinics

8. Americas Canaloplasty Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Canaloplasty Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Canaloplasty Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. FDA Approves Nova Eye Medical's Advancement in Minimally Invasive Eye Surgery
  • 11.3.2. Sight Sciences Launches the Ergo Series OmniR for Enhanced Canaloplasty Procedures
  • 11.3.3. Unlocking New Frontiers in Glaucoma Treatment with the Research Alliance Between Verana Health and Sight Sciences
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Carl Zeiss Meditec AG
• 2. Ellex Medical Pty Ltd.
• 3. Glaukos Corporation
• 4. iSTAR Medical
• 5. Nova Eye Medical Limited
• 6. Qura, Inc.
• 7. Sight Sciences, Inc.